Home/Filings/4/0001179110-11-016032
4//SEC Filing

Chambers Michael 4

Accession 0001179110-11-016032

CIK 0001222244other

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 3:29 PM ET

Size

14.0 KB

Accession

0001179110-11-016032

Insider Transaction Report

Form 4
Period: 2011-12-01
Transactions
  • Award

    Common stock, $0.00001 par value

    2011-12-01$1.10/sh+8,182$9,000134,479 total
  • Award

    Convertible Note

    2011-12-01$1.00/sh
    Exercise: $1.10Exp: 2012-02-28Common stock, $0.00001 par value
Holdings
  • Warrants

    Exercise: $1.30Exp: 2014-01-07Common stock, $0.00001 par value (73,776 underlying)
    73,776
  • Warants

    Exercise: $0.50Exp: 2012-12-31Common stock, $0.00001 par value (10,000 underlying)
    10,000
  • Options

    Exercise: $1.72Exp: 2017-08-10Common stock, $0.00001 par value (14,535 underlying)
    14,535
  • Stock options

    Exercise: $0.87Exp: 2018-08-09Common stock, $0.00001 par value (28,736 underlying)
    28,736
  • Options

    Exercise: $2.41Exp: 2017-03-01Common stock, $0.00001 par value (10,374 underlying)
    10,374
Footnotes (5)
  • [F1]Currently exercisable.
  • [F2]Options vest as to 433 shares per month beginning April 1, 2010 through February 1, 2010 and as to 415 shares on March 1, 2012.
  • [F3]Annual option award pursuant to the Issuer's compensation policy for Directors upon their re-election to the Board of Directors at its annual shareholders' meeting. The seven-year options vest ratably over 12 months.
  • [F4]On December 1, 2011, the reporting person and the Company executed a convertible promissory note in the principal amount of $6,400 with a maturity date of February 28, 2012. The principal amount and interest accruing at a rate of 10% per year are convertible into common shares at $1.10 per share at any time through the maturity date. The number of shares to be issued upon conversion will be fixed on the conversion date and reported on a Form 4 within 2 business days after conversion. The transaction was approved by the Company's Board of Directors and is exempt under section 16b-3(d).
  • [F5]Shares issued in lieu of cash for directors' fees as approved by the Board of Directors which are exempt under section 16b-3(d).

Issuer

ProUroCare Medical Inc.

CIK 0001222244

Entity typeother

Related Parties

1
  • filerCIK 0001485975

Filing Metadata

Form type
4
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 3:29 PM ET
Size
14.0 KB